Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J3CT
|
||||
Former ID |
DNC012790
|
||||
Drug Name |
FK-143
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Prostate disease [ICD10:N42.9] | Phase 2 | [545399] | ||
Structure |
Download2D MOL |
||||
Formula |
C40H44N2O3
|
||||
Canonical SMILES |
CC(C)CC1=CC=C(C=C1)C(C2=CC=C(C=C2)CC(C)C)NC3=CC=CC(=C3)<br />C(=O)C4=CN(C5=CC=CC=C54)CCCC(=O)O
|
||||
InChI |
1S/C40H44N2O3/c1-27(2)23-29-14-18-31(19-15-29)39(32-20-16-30(17-21-32)24-28(3)4)41-34-10-7-9-33(25-34)40(45)36-26-42(22-8-13-38(43)44)37-12-6-5-11-35(36)37/h5-7,9-12,14-21,25-28,39,41H,8,13,22-24H2,1-4H3,(H,43,44)
|
||||
InChIKey |
LACIBZRFAYFTOV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-alpha reductase | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.